Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$6.71 - $11.83 $18,445 - $32,520
2,749 Added 7.39%
39,949 $268,000
Q2 2023

Aug 21, 2023

BUY
$11.12 - $22.2 $2,068 - $4,129
186 Added 0.5%
37,200 $426,000
Q1 2023

May 09, 2023

BUY
$18.7 - $23.07 $7,816 - $9,643
418 Added 1.14%
37,014 $745,000
Q4 2022

Feb 14, 2023

BUY
$18.12 - $27.32 $8,552 - $12,895
472 Added 1.31%
36,596 $829,000
Q3 2022

Nov 18, 2022

SELL
$16.98 - $25.54 $3,701 - $5,567
-218 Reduced 0.6%
36,124 $678,000
Q2 2022

Aug 15, 2022

BUY
$13.15 - $20.45 $92,825 - $144,356
7,059 Added 24.11%
36,342 $677,000
Q4 2021

Feb 15, 2022

BUY
$20.24 - $36.01 $21,798 - $38,782
1,077 Added 3.82%
29,283 $607,000
Q3 2021

Nov 15, 2021

BUY
$26.01 - $38.22 $733,638 - $1.08 Million
28,206 New
28,206 $903,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $740M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.